MedPath

To determine how the treatment with physical activity and yoga program for 12 weeks will bring change in leptin (a satiety hormone secreted by adipose tissue) resistance in people with metabolic syndrome

Not Applicable
Conditions
Health Condition 1: E660- Obesity due to excess calories
Registration Number
CTRI/2020/11/029212
Lead Sponsor
Department of Science and technology Science and technology in yoga and meditation DSTSATYAM
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Participants with age group above

30 years to 50 years, either gender are included in the study. Participants will be included on the basis of metabolic syndrome parameters like waist circumference >94cm for males and >80cmfor females, BMI >25kg/m2, fasting blood glucose >100mg/dl, blood pressure >130/85mmhg,

serum triglycerides >150mg/dl, HDL <40mg/dl for males and <50 mg/dl serum leptin levels >

9.5ng/ml for males >25.0ng/ml for females, sedentary lifestyle according to GPAQ screening

Exclusion Criteria

History of smoking past 6 months, Cardiovascular disease, Stroke, TIA, Any cognitive impairment, Any recent surgeries which hinder with physical activity, Systemic illness

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
leptin resistance <br/ ><br>quality of lifeTimepoint: Baseline <br/ ><br>12 weeks <br/ ><br>6months
Secondary Outcome Measures
NameTimeMethod
Body composition, BMR, Homocysteine, Fasting Insulin LevelTimepoint: Baseline <br/ ><br>12 weeks <br/ ><br>6months
© Copyright 2025. All Rights Reserved by MedPath